EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallbericht

Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII : A case report and literature review

Yuya Ito iD, Shunichiro Tsuji iD, Makiko Kasahara, Shinsuke Tokoro iD, Takashi Murakami, Hiroshi Takayama

Journal of Obstetrics and Gynaecology Research · 2024

DOI: 10.1111/jog.15819 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Yuya Ito und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu City, Shiga, Japan. Hauptthemen laut MEDLINE: Factor XIII Deficiency, Abortion, Habitual. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Factor XIII deficiency is an extremely rare autosomal recessive genetic disorder, occurring in 1 of 3–5 million people, and is associated with perinatal complications, such as habitual abortion and prolonged bleeding. Although plasma‐derived factor XIII (Fibrogamin®) carries a risk of infection and contains very low concentrated forms of factor XIII (FXIII) used for a pregnant woman with congenital coagulation factor XIII deficiency, recombinant factor XIII (rFXIII, Novo Thirteen®; Tretten®, Novo Nordisk, Bagsværd, Denmark), which has no risk of infection and is highly concentrated, has emerged as a novel formulation. Herein, we report the first case of a Japanese pregnant woman with congenital coagulation factor XIII deficiency successfully managed by rFXIII. She had a good perinatal course without pregnancy‐related complications and transfusion through the perinatal period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor XIII DeficiencyAbortion, HabitualPregnancyFemaleHumansFactor XIIIRecombinant ProteinsBlood Coagulation

Stichwörter der Autor:innen

Novo Thirteencongenital factor XIII deficiencyfactor XIIIpregnant womanreplacement therapy

Substanzen

Factor XIIIRecombinant Proteins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu City, Shiga, Japan.
  • Department of Internal Medicine, Takashima Municipal Hospital, Takashima City, Shiga, Japan.

ORCID-Profile: Yuya Ito, Shunichiro Tsuji, Shinsuke Tokoro

Zitieren

APA

Ito, Y., Tsuji, S., Kasahara, M., Tokoro, S., Murakami, T., & Takayama, H. (2024). Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII : A case report and literature review. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15819

Vancouver

Ito Y, Tsuji S, Kasahara M, Tokoro S, Murakami T, Takayama H. Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII : A case report and literature review. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.15819

BibTeX
@article{Ito2024,
  author = {Ito, Yuya and Tsuji, Shunichiro and Kasahara, Makiko and Tokoro, Shinsuke and Murakami, Takashi and Takayama, Hiroshi},
  title = {Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII : A case report and literature review},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2024},
  doi = {10.1111/jog.15819}
}
Kostenlos starten →